Use of Long-Acting Muscarinic Antagonists and Biologics as Add-On Therapy for Patients With Asthma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Usage of Long-Acting Muscarinic Antagonists and Biologics as Add-On Therapy for Patients in the United States With Moderate-to-Severe Asthma
J Asthma 2021 May 22;[EPub Ahead of Print], CV Spain, P Dayal, Y Ding, C Iribarren, TA Omachi, H ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.